Minnesota Bill HF5247

Link to Full Minnesota Bill (over 1400 pages):   https://www.revisor.mn.gov/bills/text.php?number=HF5247&type=bill&version=4&session=ls93&session_year=2024&session_number=0&format=pdf

Accessible Bill Excerpt:

Article 60 Sec. 10.  REVISOR EAP H5247-4HF5247 FOURTH ENGROSSMENT

Accessible prescription drug container labels. 

(a) A pharmacy must:

(1) make reasonable efforts to inform the public that an accessible prescription drug
container label is available at no additional cost, upon request of the patient or the patient's
representative, to any patient who has difficulty seeing or reading standard printed labels
on prescription drug containers; and
(2) if the pharmacy knows that the patient has difficulty seeing or reading standard
printed labels on prescription drug containers, inform a patient that an accessible prescription
drug container label is available at no additional cost upon request of the patient or the
patient's representative.

(b) Subject to paragraph (e), if a patient requests an accessible container label, the
pharmacy must provide the patient with a prescription drug container label in large print,
Braille, or may provide any other method included in the best practices for access to
prescription drug labeling information by the United States Access Board, or its successor
organization, depending on the need and preference of the patient. The pharmacy must make
reasonable efforts to ensure patient safety and access during the time it takes to provide the
requested method of accessibility.
 

(c) The accessible container label must:

(1) be affixed on the container in compliance with section 151.212, subdivision 1;
(2) last for at least the duration of the prescription;
(3) contain the information required under subdivisions 1 and 2;
(4) be available in a timely manner relative to the industry standard time required to
produce the accessible container label; and
(5) conform with the best practices established by the United States Access Board, or
its successor organization, for large print and Braille accessible container labels.

(d) By January 1, 2025, the commissioner of health must publish a list of pharmacies
that have informed the commissioner that the pharmacy has the technological capacity to provide an accessible container label to a patient in the timely manner required by paragraph (c), clause (4). The commissioner must update this list on a quarterly basis until January 1, 2026.

(e) Until January 1, 2026, if the pharmacy does not have the technological capacity to provide an accessible container label to a patient in the timely manner required by paragraph(c), clause (4), the pharmacy is not required to provide an accessible container label to a patient requesting such a label, but the pharmacy must inform the patient of the list of pharmacies with such capacity required pursuant to paragraph (d), if such list is published. 

(f) On and after January 1, 2026, all pharmacies must be able to provide an accessible container label in the timely manner required by paragraph (c), clause (4). 

(g) This subdivision does not apply to prescription drugs dispensed and administeredby a correctional institution.EFFECTIVE DATE. This section is effective January 1, 2025.